Ian Lobb

1.1k total citations
28 papers, 804 citations indexed

About

Ian Lobb is a scholar working on Biochemistry, Molecular Biology and Surgery. According to data from OpenAlex, Ian Lobb has authored 28 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biochemistry, 11 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Ian Lobb's work include Sulfur Compounds in Biology (15 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Liver Disease and Transplantation (7 papers). Ian Lobb is often cited by papers focused on Sulfur Compounds in Biology (15 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Liver Disease and Transplantation (7 papers). Ian Lobb collaborates with scholars based in Canada, United Kingdom and United States. Ian Lobb's co-authors include Alp Şener, James A. Nathan, Aaron Haig, Guinevere L. Grice, Stephen P. Burr, Paul J. Lehner, Lan Zhu, Amy Mok, Manujendra N. Saha and Michael Davison and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Ian Lobb

27 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Lobb Canada 16 372 358 157 133 95 28 804
Tetsutaro Nagaoka Japan 16 342 0.9× 63 0.2× 102 0.6× 84 0.6× 83 0.9× 43 1.2k
Lihua Ying United States 17 358 1.0× 49 0.1× 153 1.0× 91 0.7× 83 0.9× 27 1.0k
Xiaobo Chen China 9 308 0.8× 144 0.4× 79 0.5× 47 0.4× 26 0.3× 32 594
Jennifer Kleinhenz United States 11 280 0.8× 88 0.2× 62 0.4× 112 0.8× 21 0.2× 18 616
Lingdi Wang China 16 366 1.0× 24 0.1× 166 1.1× 78 0.6× 52 0.5× 24 742
Raul Lazaro United States 8 249 0.7× 30 0.1× 41 0.3× 54 0.4× 184 1.9× 8 570
Bernadette Chen United States 18 191 0.5× 85 0.2× 157 1.0× 88 0.7× 13 0.1× 39 782
Sylvia V. Reyna United States 7 256 0.7× 128 0.4× 40 0.3× 38 0.3× 42 0.4× 8 451
Prasanna Tamarapu Parthasarathy United States 16 493 1.3× 42 0.1× 76 0.5× 193 1.5× 26 0.3× 25 799
Elizabeth Tomlinson United States 7 884 2.4× 19 0.1× 342 2.2× 63 0.5× 28 0.3× 8 1.3k

Countries citing papers authored by Ian Lobb

Since Specialization
Citations

This map shows the geographic impact of Ian Lobb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lobb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lobb more than expected).

Fields of papers citing papers by Ian Lobb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Lobb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lobb. The network helps show where Ian Lobb may publish in the future.

Co-authorship network of co-authors of Ian Lobb

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Lobb. A scholar is included among the top collaborators of Ian Lobb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Lobb. Ian Lobb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wappett, Mark, Julien Daubriac, Ian Lobb, et al.. (2024). USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF. Clinical and Translational Medicine. 14(4). e1648–e1648. 9 indexed citations
2.
McClafferty, Heather, Michael J. Shipston, Richard D. Wilkinson, et al.. (2023). Oxidation modulates LINGO2-induced inactivation of large conductance, Ca2+-activated potassium channels. Journal of Biological Chemistry. 299(3). 102975–102975. 5 indexed citations
3.
Wappett, Mark, et al.. (2021). SynLeGG: analysis and visualization of multiomics data for discovery of cancer ‘Achilles Heels’ and gene function relationships. Nucleic Acids Research. 49(W1). W613–W618. 5 indexed citations
4.
Ortmann, Brian M., Natalie Burrows, Ian Lobb, et al.. (2021). The HIF complex recruits the histone methyltransferase SET1B to activate specific hypoxia-inducible genes. Nature Genetics. 53(7). 1022–1035. 45 indexed citations
5.
Lobb, Ian, Pierre Morin, Kirsty J. Martin, et al.. (2020). A Role for the Autophagic Receptor, SQSTM1/p62, in Trafficking NF-κB/RelA to Nucleolar Aggresomes. Molecular Cancer Research. 19(2). 274–287. 7 indexed citations
6.
Burr, Stephen P., James C. Williamson, Ian Lobb, et al.. (2018). MARCH6 and TRC8 facilitate the quality control of cytosolic and tail‐anchored proteins. EMBO Reports. 19(5). 61 indexed citations
7.
Juriasingani, Smriti, Masoud Akbari, Peng Shao, et al.. (2018). Endogenous H2S production deficiencies lead to impaired renal erythropoietin production. Canadian Urological Association Journal. 13(7). E210–E219. 12 indexed citations
8.
Lian, Dameng, Weihua Liu, Aaron Haig, et al.. (2018). Daily therapy with a slow-releasing H 2 S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction. Nitric Oxide. 76. 16–28. 14 indexed citations
9.
Dugbartey, George J., Hjalmar R. Bouma, Manujendra N. Saha, et al.. (2017). A Hibernation-Like State for Transplantable Organs: Is Hydrogen Sulfide Therapy the Future of Organ Preservation?. Antioxidants and Redox Signaling. 28(16). 1503–1515. 28 indexed citations
10.
Olvera‐Posada, Daniel, et al.. (2017). A novel approach to off-clamp partial nephrectomy demonstrates significant improvements in renal injury in an experimental porcine model. Canadian Urological Association Journal. 11(10). E390–5. 1 indexed citations
11.
Lobb, Ian, J. Jiang, Aaron Haig, et al.. (2016). Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia–Reperfusion Injury via Specific Mitochondrial Actions. American Journal of Transplantation. 17(2). 341–352. 53 indexed citations
12.
Dugbartey, George J., Hjalmar R. Bouma, Ian Lobb, & Alp Şener. (2016). Hydrogen sulfide: A novel nephroprotectant against cisplatin-induced renal toxicity. Nitric Oxide. 57. 15–20. 34 indexed citations
13.
Saha, Manujendra N., et al.. (2016). Hydrogen Sulfide Induced Erythropoietin Synthesis is Regulated by HIF Proteins. The Journal of Urology. 196(1). 251–260. 16 indexed citations
14.
Burr, Stephen P., Ana S.H. Costa, Guinevere L. Grice, et al.. (2016). Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. Cell Metabolism. 24(5). 740–752. 120 indexed citations
15.
Grice, Guinevere L., Ian Lobb, Michael P. Weekes, et al.. (2015). The Proteasome Distinguishes between Heterotypic and Homotypic Lysine-11-Linked Polyubiquitin Chains. Cell Reports. 12(4). 545–553. 68 indexed citations
16.
Postenka, Carl O., C. Mazzola, Matthew D. Hammers, et al.. (2015). Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential. Nitric Oxide. 49. 26–39. 26 indexed citations
17.
Lobb, Ian, et al.. (2014). Hydrogen sulfide treatment improves long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury. Canadian Urological Association Journal. 8(5-6). 413–413. 46 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsutaro Nagaoka Breakdown of academic impact, for papers by Lihua Ying Breakdown of academic impact, for papers by Xiaobo Chen Breakdown of academic impact, for papers by Jennifer Kleinhenz Breakdown of academic impact, for papers by Lingdi Wang Breakdown of academic impact, for papers by Raul Lazaro Breakdown of academic impact, for papers by Bernadette Chen Breakdown of academic impact, for papers by Sylvia V. Reyna Breakdown of academic impact, for papers by Prasanna Tamarapu Parthasarathy Breakdown of academic impact, for papers by Elizabeth Tomlinson
Rankless by CCL
2026